Related Experiment Video
Updated: Jul 14, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Improved diagnostic testing and malaria treatment practices in Zambia
Davidson H Hamer1, Micky Ndhlovu, Dejan Zurovac
1Center for International Health and Development, Boston University School of Public Health, Boston, Mass 02118, USA. dhamer@bu.edu
JAMA
|May 24, 2007
Summary
Malaria diagnostics are underused in Zambia, leading to frequent overtreatment with antimalarials even when tests are negative. Improved diagnostic use requires changes in clinical practice for fever patients without confirmed malaria.
Area of Science:
- Medical Diagnostics
- Infectious Disease Research
- Public Health
Background:
- Improving malaria diagnosis accuracy with rapid antigen-detection diagnostic tests (RDTs) is crucial for reducing overtreatment.
- Artemisinin-based combination therapy is widely implemented in sub-Saharan Africa.
Purpose of the Study:
- To assess the association between the use of microscopy and RDTs and antimalarial prescription rates.
- To evaluate diagnostic test utilization and antimalarial prescribing patterns in Zambian health facilities.
Main Methods:
- A cross-sectional, cluster sample survey was conducted in March-May 2006.
- Data collected from outpatients at government and mission health facilities in 4 sentinel districts in Zambia.
- Proportions of patients undergoing malaria diagnostic procedures and receiving antimalarial treatment were analyzed.
Main Results:
- Only 17% of facilities had functional microscopy; 63% had RDTs available.
- 27.8% of febrile patients with available diagnostics were tested, with 44.6% testing positive.
- 58.4% of patients with negative blood smear results and 35.5% with negative RDT results were prescribed antimalarials.
- 65.9% of febrile patients without diagnostic tests also received antimalarials.
Conclusions:
- Malaria diagnostics remain underused in Zambia, with frequent prescription of antimalarials despite negative test results.
- Effective reduction of inappropriate antimalarial use requires integrating new diagnostic tools with significant changes in clinical management for fever patients.
- Clinical practice for patients presenting with fever but lacking confirmed malaria infection needs substantial modification.
Related Concept Videos
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

